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The Wnt genes are known to play fundamental roles during patterning and development of a number of embryonic
structures. Receptors for Wnts are members of the Frizzled family of proteins containing a cysteine-rich domain (CRD) that
binds the Wnt protein. Recently several secreted frizzled-related proteins (Sfrps) that also contain a CRD have been
identified and some of these can both bind and antagonise Wnt proteins. In this paper we report the expression patterns of
the chick homologues of Frzb, a known Wnt antagonist, and Sfrp-2. Both genes are expressed in areas where Wnts are
nown to play a role in development, including the neural tube, myotome, cartilage, and sites of epithelial–mesenchymal
nteractions. Initially, Sfrp-2 and Frzb are expressed in overlapping areas in the neural plate and neural tube, whereas later,
hey have distinct patterns. In particular Sfrp-2 is associated with myogenesis while Frzb is associated with chondrogenesis,
uggesting that they play different roles during development. Finally, we have used the early Xenopus embryo as an in vivo
ssay to show that Sfrp-2, like Frzb, is a Wnt antagonist. These results suggest that Sfrp-2 and Frzb may function in the
eveloping embryo by modulating Wnt signalling. © 2000 Academic Press
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The Wnt gene family consists of at least 16 secreted
glycoproteins that play fundamental roles during patterning
and morphogenesis of a number of embryonic structures
Sequence data from this article have been deposited with the
GenBank Data Library under Accession Nos. AF218056 and
AF218057.
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All rights of reproduction in any form reserved.reviewed by Parr and McMahon, 1994; Wodarz and Nusse,
998). For example, Wnt signalling patterns the dorsoven-
ral axis of the early Xenopus embryo (McMahon and Moon,
989; Moon et al., 1997) and of the developing limb bud in
ice and chicks (Kengaku et al., 1998; Parr and McMahon,
995; Riddle et al., 1995; Yang and Niswander, 1995).
uring somite development, Wnt signalling from the neu-
al tube controls formation of the medial dermamyotome
Mu¨nsterberg et al., 1995; Ikeya and Takada, 1998). In the
idney, Wnt-4 is required for the mesenchymal to epithelial
ransformation of the metanephrogenic mesenchyme to
orm the epithelial nephrons (Stark et al., 1994), whilst
uring skeletal development, Wnt-1, Wnt-5a, and Wnt-7a
an inhibit chondrogenesis (Rudnicki and Brown, 1997;
awakami et al., 1999). Functional studies in developing
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184 Ladher et al.mouse, chick, and Xenopus embryos, or in cell lines, have
shown that Wnt signalling can control several cellular
processes, including proliferation, cell transformation/fate,
and cell adhesion (reviewed by Wodarz and Nusse, 1998).
Using functional assays the Wnt family has been subdi-
vided into at least two subclasses. In Xenopus, Wnt-1,
Wnt-3a, and Wnt-8 are able to induce axis duplication in
embryos, whereas Wnt-4, Wnt-5a, and Wnt-11 block
activin-induced morphogenetic movements in blastula caps
but cannot duplicate the Xenopus axis (Du et al., 1995). In
ebrafish embryos, signalling by Wnt-5a, but not Wnt-8,
nduces an increase in intracellular calcium (Slusarski et
l., 1997a,b). The Wnt gene family has also been subdivided
nto those that can transform the C57MG mammary epi-
helial cell line (Wnt-1, Wnt-3a, and Wnt-7a), those that
annot (Wnt-4 and Wnt-5a), and those that can only weakly
ransform C57MG cells (Wnt-2, Wnt-5b, and Wnt-7b; Wong
t al., 1994).
The frizzled family consists of at least 11 members in
ertebrates (Wang et al., 1996), some of which have been
hown to function as Wnt receptors. They are integral
embrane proteins containing an N-terminal extracellular
ysteine-rich domain with 10 cysteines, known as the CRD
r frizzled domain, and seven putative transmembrane
egments together with an intracellular domain. CRDs,
hich can directly bind Wnt proteins (Bhanot et al., 1996;
in et al., 1997; Wang et al., 1997; Lescher et al., 1998;
afico et al., 1999), have also been identified in another
roup of genes known as the secreted frizzled-related pro-
eins (Sfrps). They include Sfrp-1 (also known as hFRP,
FrzA, and SARP2), Sfrp-2 (also called SARP1 and SDF-5),
rzb (Sfrp-3 and Fritz), Sfrp-4, SARP3, sizzled, and crescent,
hich have so far been characterised in humans, mice,
hick, and Xenopus (Shirozu et al., 1996; Finch et al., 1997;
ayr et al., 1997; Melkonyan et al., 1997; Pfeffer et al.,
997; Rattner et al., 1997; Salic et al., 1997; Hoang et al.,
998; Leimeister et al., 1998; Lescher et al., 1998). In
ddition to the CRD, Sfrps also contain a novel C-terminus
hat lacks both the transmembrane and the intracellular
equences of the frizzled gene family. Functional studies in
enopus have shown that Frzb, Sfrp-1, and sizzled can
ntagonise signalling by specific Wnt proteins. Sizzled
locks Wnt-8 signalling; Frzb inhibits Wnt-1 and Wnt-8, but
ot Wnt-3a, Wnt-5a, and Wnt-11; whilst XSfrp-1 (FrzA)
nhibits Wnt-1, Wnt-2, Wnt-8, and to a lesser extent Wnt-
a, but does not block signalling by Wnt-5a (Leyns et al.,
997; Mayr et al., 1997; Salic et al., 1997; Wang et al., 1997;
u et al., 1998). The ability of the other Sfrps to inhibit Wnt
ignalling has not yet been reported. However, together
ith cerberus, dickkopf-1, and the recently identified WIF-1
rotein, which are all secreted and can antagonise Wnt
ignalling, they form one group of proteins that may be
ritical in modulating Wnt function (Glinka et al., 1998;
sieh et al., 1999; Piccolo et al., 1999).
Sfrp-1, Sfrp-2, Sfrp-4, and Frzb are expressed in a number
f regions where they may modify Wnt signalling in devel-
ping mouse and human embryos (Finch et al., 1997; Hoang
Copyright © 2000 by Academic Press. All rightt al., 1996, 1998; Rattner et al., 1997; Leimeister et al.,
998; Lescher et al., 1998). In the chick, only the expression
f crescent, which is found in the anterior endoderm during
astrulation, has been reported (Pfeffer et al., 1997). In this
aper we describe the cloning and expression of two other
frp family members, Sfrp-2 and Frzb, during chick devel-
opment. We compare their expression during neurogenesis;
during formation of the limb bud, somites, and heart; and in
the development of the face. Finally, we show that chick
Frzb and chick Sfrp-2 hyperdorsalise injected Xenopus em-
bryos and block the dorsalising activity of Xwnt-8 in ventral
marginal zone explants. These results suggest that cFrzb
and cSfrp-2 are antagonists of Wnt proteins.
MATERIALS AND METHODS
Chick Embryos
Fertilised Ross White chicken eggs were supplied by Poyndon
Farm (Goff’s Oak, Hertfordshire, UK) and were incubated at 38 6
1°C in humidified incubators. Embryos were staged according to
Hamburger and Hamilton (1951).
Cloning of Sfrp-2 and Frzb
Homologues of Sfrp-2 and Frzb were obtained by screening a
tage 12 chick Lambda ZAP II cDNA library under low-stringency
onditions as described by Francis et al. (1994). 32P-Labelled
random-primed DNA probes were made from fragments encoding
amino acids 49 to 242 of mouse Sfrp-2 and the full-length bovine
Frzb coding sequence (Hoang et al., 1996). The mouse Sfrp-2
fragment was obtained by PstI digestion of IMAGE clone 536389
from the EST database (Lennon et al., 1996). From 106 plaques, 28
Sfrp-2 positives and 19 Frzb positives were identified in the primary
creen, and 10 and 13 clones, respectively, were purified to comple-
ion under the same conditions. The Bluescript plasmids encoding
he Sfrp-2 and Frzb homologues were excised following standard
rocedures (Stratagene). Following restriction analysis, dideoxy
equencing of both strands was carried out on three independent
rzb cDNAs and one Sfrp-2 cDNA with Sequenase version 2 or a T7
equencing kit (Amersham Pharmacia Biotech) using denatured
ouble-stranded DNA templates. Nucleotide sequences were as-
embled using the Assemblylign computer program (Oxford Mo-
ecular) and the inferred protein sequences were compared with
nown sequences from GenBank. The DNA sequences have been
eposited in the GenBank database.
RNA Studies
Total RNA was extracted from stage 28 embryos using Trizol
(Gibco Life Technologies) and poly(A)1 RNA was subsequently
isolated using a PolyATtract mRNA Isolation system IV (Promega)
according to the manufacturer’s instructions. Two micrograms of
poly(A)1 RNA was denatured with 1.2 M glyoxal, 53% DMSO, and
0.01 M sodium phosphate (pH 7) for 1 h at 50°C before size
fractionating on a 1.2% agarose/0.01 M sodium phosphate (pH 7)
gel. The RNA was then transferred onto a Hybond-N membrane
(Amersham Pharmacia Biotech) and hybridised overnight with
radiolabelled probe and washed as described by Francis et al. (1994).
s of reproduction in any form reserved.
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185Sfrp-2 and Frzb during Chick DevelopmentDNA Constructs
The Sfrp-2 antisense probe was generated by linearising the
full-length clone with HindIII and transcribing with T3 RNA
polymerase. Sense Sfrp-2 transcripts were generated with T7 RNA
polymerase using SmaI-linearised Sfrp-2 DNA as a template. The
PstI fragment encoding nucleotides 667 to 1859 of Frzb was
subcloned into pBluescript SK (1). This region encodes part of the 39
egion of the Frzb protein (from amino acid 207) and 850 bp of the
9 UTR. Antisense probes for in situ hybridisation and Northern
analyses of Frzb were synthesised with T3 RNA polymerase using
XhoI-digested plasmid. Sense control probes were obtained with T7
polymerase using XbaI-digested plasmid. Full-length chick Sfrp-2
and Frzb were subcloned into the CS21 vector (Rupp et al., 1994)
and RNA was transcribed with SP6 RNA polymerase using NotI-
linearised plasmid as a template. Sox9 (Kent et al., 1996), Slug
(Nieto et al., 1994), Wnt-1 (Hollyday et al., 1995), and Wnt-8c
(Hume and Dodd, 1993) were used as previously described.
In Situ Hybridisation to Whole Mounts and Tissue
Sections
Embryos were fixed in 4% (w/v) paraformaldehyde and processed
through a methanol series for whole-mount in situ hybridisation as
escribed by Francis-West et al. (1994) for older embryos (stages 17
o 28) and by Myat et al. (1996) for younger embryos. Alternatively,
fter fixation embryos were processed into wax for radioactive in
itu hybridisation as described by Barlow and Francis-West (1997).
Xenopus Experiments
Xenopus embryos were obtained by artificial fertilisation as
escribed (Dale and Slack, 1987). The embryos were dejellied in 2%
ysteine hydrochloride (pH 8.1) and staged according to Nieuw-
oop and Faber (1967). They were then transferred into 10% normal
mphibian medium (NAM; 110 mM NaCl, 2 mM KCl, 1 mM
a(NO3)2, 1 mM MgSO4, 0.1 mM Na2EDTA, 1 mM NaHCO3,
Hepes buffer, pH 7.5) supplemented with 4% Ficoll. For the
whole-embryo phenotype experiments one ventral blastomere was
injected at the four-cell stage with 1 ng of either Sfrp-2 or Frzb
RNA and embryos were cultured until stage 36 when hyperdor-
alised embryos were scored using the dorsoanterior index of Kao
nd Elinson (1988). Briefly, normal embryos are given a score of 5
hile fully dorsalised embryos are given a score of 10. For ventral
arginal zone (VMZ) explants both ventral blastomeres were
njected at the four-cell stage with 20 pg of Xwnt-8 mRNA
Christian et al., 1991) or with a mixture of 20 pg of Xwnt-8 and 2
g of either Sfrp-2 or Frzb mRNA. Ventral marginal zones were
xplanted at stage 10.5 (early gastrulae) and cultured in 50% NAM
ntil sibling embryos had reached stage 30. They were then fixed in
.1 M Mops, pH 7.4; 2 mM EGTA; 1 mM MgSO4; 3.7% formalde-
yde for 2 h and dehydrated in methanol. Muscle was detected in
xplants by whole-mount immunolocalisation using the 12/101
onoclonal antibody (Kintner and Brockes, 1984), while blood was
etected using an anti-globin polyclonal antibody (kindly provided
y Jim Smith). Briefly, after rehydration, the explants were
leached in 6% hydrogen peroxide in TBST (TBS with 0.15%
riton X-100). Free ends of proteins were blocked using 1 M glycine
pH 7.5) for 30 min followed by 3 3 30-min washes in TBSBT (TBS
ith 2 mg/ml BSA and 0.15% Triton X-100). The explants were
laced in a blocking solution (TBSBT with 10% goat serum) for 2 h
nd then a 1:500 dilution of 12/101 and the anti-globin antibody in
Copyright © 2000 by Academic Press. All rightBSBT with 10% goat serum. After incubating overnight at 4°C
xplants were washed for 5 3 1 h in TBSBT and the monoclonal
ntibody (12/101) was detected using an anti-mouse Fab fragment
onjugated to alkaline phosphatase (Roche Diagnostics), whilst the
olyclonal antibody was detected using a biotinylated anti-rabbit
ntibody (DAKO). Explants were washed for 5 3 1 h in TBSBT with
final wash overnight at 4°C. Embryos were then incubated for 1 h
n ABC solution (Vector Laboratories) in TBSBT with 2% goat
erum and then washed 4 3 15 min in TBST. Alkaline phosphatase
ctivity was detected by rinsing first in 100 mM Tris, pH 9.5; 20
M MgCl2; 10 mM NaCl; 1% Tween 20, before the explants were
stained using BM-purple precipitating substrate (Roche Diagnos-
tics). Once alkaline phosphatase staining was complete, the ex-
plants were rinsed in TBS and then HRP activity was detected
using the VIP substrate (Vector Laboratories) which produces a red
product.
For animal cap experiments, two-cell-stage embryos were in-
jected with 20 pg of Xwnt-8 mRNA (Christian et al., 1991) or with
a mixture of 20 pg of Xwnt-8 and 2 ng of either Sfrp-2 or Frzb
mRNA and allowed to develop until stage 8. Animal caps were
explanted and cultured until sibling controls had reached early
gastrula stages (stage 10.5) and then frozen and RNA was extracted.
siamois and Ef-1a transcripts were detected using RT-PCR. Con-
itions for Ef-1a amplification were 94°C for 1 min, 55°C for 1 min,
nd 72°C for 1 min for 20 cycles using the primers CAG ATT GGT
CT GGA TAT GC (forward) and ACT GCC TTG ATG ACT CCT
G (reverse). Identical conditions were used for siamois, except
hat 30 cycles were performed, using the primers AAG ATA ACT
GC ATT CCT GAG C (forward) and GGT AGG GCT GTG TAT
TG AAG G (reverse). Amplified products were detected by
lectrophoresis on a 2% agarose gel.
RESULTS
Isolation and Sequence of Sfrp-2 and Frzb
Chick Sfrp-2 and Frzb cDNA clones were isolated from a
tage 12 cDNA library using cDNA fragments encoding the
ouse and the bovine homologues, respectively. Ten Sfrp-2
nd 13 Frzb clones were purified and were characterised by
estriction mapping. Sequence analysis of the longest
DNAs showed that chick Sfrp-2 and Frzb encode proteins
consisting of 292 and 315 amino acids, respectively. Both
contain the 10 conserved cysteine residues characteristic of
the CRD found in other Sfrps and members of the frizzled
family. Comparison of the inferred amino acid sequence
with the homologues in other species showed that Sfrp-2
shares 80% identity with the mouse homologue whilst Frzb
shares an average of 78% identity with the human, mouse,
bovine, and Xenopus homologues. The predicted amino
acid sequences of Sfrp-2 and Frzb, together with comparison
with the other homologues, are shown in Figs. 1A and 1B,
respectively.
Analysis of the inferred amino acid sequences using the
software PrositeScan revealed a putative N-glycosylation
site at asparagine 41 and a putative O-glycosylation site at
threonine 147 in Frzb although none were identified in
Sfrp-2. In addition, several putative hyaluronan binding
sites and a region of homology termed the FUN (Frzb/Unc-
6/netrin) domain, which has similarity to a region in the
s of reproduction in any form reserved.
1s
h
186 Ladher et al.netrin-2 and Unc-6 proteins involved in axonal guidance,
were identified (Fig. 1C; Serafini et al., 1994; Yang et al.,
FIG. 1. Amino acid alignment of (A) Sfrp-2 homologues in chicke
(B) Frzb homologues in chicken, mouse, human, cow, and Xenopus
underlined and the conserved cysteines within this domain are sho
dashes. Gaps (represented by dots) have been introduced to optim
Sfrp-2 sequence. The predicted signal sequence cleavage site of Frzb
A dagger indicates the putative N-glycosylation site at asparagine
Alignment of the FUN domain of chicken netrin-2, Caenorhabdit
bold are conserved between all four proteins. Dots indicate gaps to in
the software ClustalW 1.7.994; Leyns et al., 1997). However, in our preliminary m
Copyright © 2000 by Academic Press. All righttudies, we have not been able to demonstrate functional
yaluronan binding sites in recombinant Frzb as deter-
use, and human (Melkonyan et al., 1997; Rattner et al., 1997) and
ng et al., 1996; Leyns et al., 1997; Wang et al., 1997). The CRD is
n bold. Amino acids identical to those in chicken are indicated by
e alignment. An asterisk indicates the end of the known human
PA-GR and Sfrp-2 is STA-GL as described by Nielsen et al. (1997).
nd the putative O-glycosylation site at threonine 147 in Frzb. (C)
gans Unc-6, chicken Sfrp-2, and chicken Frzb. Residues shown in
se the alignment. The sequences in (A, B, and C) were aligned usingn, mo
(Hoa
wn i
ise th
is A
41 a
is ele
creained by its ability to bind to biotinylated hyaluronan.
s of reproduction in any form reserved.
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187Sfrp-2 and Frzb during Chick DevelopmentNorthern Analysis
The Sfrp-2 and Frzb mRNAs were analysed by Northern
blotting of poly(A)1 RNA from stage 28 embryos. Three
NA transcripts of 1.4, 2.1, and 2.6 kb, the predominant
ne being 2.1 kb, hybridised to both full-length and 39 UTR
probes for Sfrp-2, whilst a single RNA transcript of approxi-
mately 2.3 kb hybridised to the Frzb probe (Fig. 2). The
same pattern of hybridisation with both the full-length and
the 39 UTR Sfrp-2 probes suggests that the three transcripts
may be due to alternative polyadenylation sites, alternative
splicing, or promoter usage in a single gene.
Expression of Sfrp-2 and Frzb during Chick
Development
To investigate the expression of Sfrp-2 and Frzb during
mbryogenesis, in situ hybridisation was performed on
hole embryos. This showed that Sfrp-2 and Frzb are
expressed in developing neural structures and some of its
derivatives, as well as the heart, branchial arches, and limb
buds (Figs. 3–7). In early development Sfrp-2 and Frzb have
similar domains of expression, whereas in older embryos
the domains of expression are distinct. In some regions,
expression of Sfrp-2 and Frzb appears to be associated with
myogenesis and chondrogenesis, respectively.
Early Development
At stage 7, both Sfrp-2 and Frzb are expressed in the
neural plate with lower expression in the midline (Figs. 3A,
FIG. 2. Northern analysis of Sfrp-2 and Frzb mRNAs. Two micro-
rams of poly(A)1 RNA from stage 28 embryos was loaded on each
lane and hybridised for probes specific for chicken (A) Sfrp-2 and (B)
rzb. The sizes of the transcripts are marked in kilobases.3B, 3C, and 3E). Both genes are expressed in a graded
Copyright © 2000 by Academic Press. All rightmanner, with higher levels anteriorly (Figs. 3B and 3C). At
this stage, Sfrp-2 and Frzb expression encompasses Wnt-1
expression in the neural plate (data not shown) and Wnt-8c
in the presumptive rhombomere 4 and posterior neural
plate (Fig. 3D). In addition, Wnt-8c transcripts are present in
the primitive streak, Hensen’s node, and the presumptive
mesoderm (Fig. 3D and also see Hume and Dodd, 1993). By
stage 9, the expression of Sfrp-2 and Frzb is distinct. At this
stage, expression of Sfrp-2 is throughout the developing
neural tube, with lower levels in the future posterior
mesencephalon and rhombomere 3 (Fig. 3I). In anterior
regions, expression is stronger in the dorsal neural tube,
whereas more posteriorly, Sfrp-2 is expressed throughout
the closing neural tube (Figs. 3F and 3H). In contrast, Frzb is
restricted to the anterior neural tube but, as with Sfrp-2, its
expression is stronger dorsally (Figs. 3G, 3J, and 3L). In
addition, Sfrp-2 expression is also detectable in the surface
ectoderm flanking the neural tube (Figs. 3F and 3H), whilst
Frzb is found in the neural crest (Fig. 3G). There is a similar
relationship between Wnt-8c and Sfrp-2 with their expres-
sion overlapping in the posterior neural tube and presump-
tive hindbrain, whereas at this stage, Frzb expression over-
laps only with Wnt-8c in the latter region (data not shown).
However, the relationship between Wnt-1, Frzb, and Sfrp-2
is more complex. In the developing brain, Frzb and Wnt-1
ranscripts overlap (Figs. 3J and 3K), whereas Sfrp-2 and
nt-1 expressions are almost complementary (Figs. 3I and
K). Thus, Sfrp-2 transcripts but not those of Wnt-1 are
found in the presumptive forebrain whilst Wnt-1, but not
Sfrp-2 transcripts, are found at high levels in the developing
midbrain (Figs. 3I and 3K). In contrast, Wnt-1 expression
overlaps with that of Sfrp-2, but not Frzb, in the anterior
neural tube (Figs. 3I, 3J, and 3K; also see Hollyday et al.,
1995). By stage 12, Sfrp-2 expression is restricted to the
dorsal prosencephalon, hindbrain (rhombomeres 2, 4, and
6), and posterior neural tube (Figs. 3M, 3O, and 3P and data
not shown). In contrast to Sfrp-2, transcripts of Frzb are
undetectable in the anterior neural tube but, as with Sfrp-2,
transcripts are found posteriorly (Figs. 3N, 3Q, and 3S). As
earlier, Frzb transcripts are clearly detectable in the cranial
neural crest (Fig. 3N) and in addition, Frzb is expressed in
the dorsal and ventral streams of trunk neural crest (data
not shown). Frzb is also expressed in the lateral plate
mesoderm (Figs. 3Q and 3S). By this stage expression of
Wnt-8c is downregulated in rhombomere 4 but continues to
overlap with Sfrp-2 and Frzb in the posterior neural tube
(data not shown). Wnt-1 expression is complementary to
both Frzb and Sfrp-2 expression in the neural tube (Figs. 3P,
3Q, and 3R). In the developing brain, Wnt-1 and Sfrp-2 are
expressed in overlapping domains (Figs. 3P and 3R).
Expression in the Placodes
Sfrp-2 is expressed in the otic, olfactory, and epibranchial
placodes (Figs. 3M, 3P, 4A, and 4D). Expression is found
earliest in the otic placode, at stage 11, whilst the olfactory
s of reproduction in any form reserved.
o
V
a
t
188 Ladher et al.FIG. 3. Expression of Sfrp-2 and Frzb in the early developing embryo. Whole-mount in situ hybridisation showing the expression
f Sfrp-2 (B, I, P), Frzb (C, J, Q), Wnt-8c (D), and Wnt-1 (K, R) in stage 7 (B, C, D), 9 (I, J, K), and 12 (P, Q, R) embryos. (A and E)
ibratome sections through B and C, respectively, showing expression in the neural plate. (F, H and G, L) Sections through the
nterior and posterior regions of embryos I and J, respectively, showing dorsally restricted expression in the anterior neural
ube (F, G) and Sfrp-2 expression throughout the posterior closing neural tube (H), whereas Frzb expression in this region is
negligible (L). (M and N) Sections through rhombomere 6 of the embryos in P and Q, respectively, showing expression of Sfrp-2
in the dorsal neural tube and otic placode and expression of Frzb in the cranial neural crest. (O and S) Sections through the
posterior region of embryos P and Q, respectively, showing expression of Sfrp-2 in the neural tube and dermamyotome (O)
and Frzb in the lateral plate mesoderm (S; the section is oblique and thus there is expression on the left-hand side only). In B, C, D,
I, J, K, P, Q, and R, anterior is uppermost. In the sections the dorsal side is uppermost. d, dermamyotome; h, developing hindbrain;
lpm, lateral plate mesoderm; me, mesencephalon; nc, neural crest; np, neural plate; nt, neural tube; op, otic placode; se, surface
ectoderm.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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Copyright © 2000 by Academic Press. All rightand epibranchial placodes express Sfrp-2 by stage 15. Frzb is
found in the epibranchial placodes from stage 18 (Fig. 4E).
Expression of Sfrp-2 and Frzb in the Facial
Primordia
Initially, Frzb is expressed in the neural crest emanating
from the midbrain, as shown by comparison with slug
expression (Figs. 4B and 4C), and from the hindbrain (Figs.
3G, 3J, 3N, 3Q, and 4B), whilst Sfrp-2 is expressed in some
of the placodes (Figs. 3M, 3P, 4A, and 4D).
By whole-mount in situ hybridisation Sfrp-2 expression
was detected throughout the ectoderm of the facial primor-
dia at stage 20 with negligible levels in the mesenchyme
(Fig. 4D). By stage 24, there are high levels of mesenchymal
expression in a small region of the posterior maxillary
primordia and the lateral region of the mandibular primor-
dia (Fig. 4F). In addition, Sfrp-2 is expressed in the mesen-
chyme in the lateral nasal process (Fig. 4F). By stage 28,
Sfrp-2 appears to be associated with a subset of muscles. For
example, comparison with MyoD expression shows that
Sfrp-2 transcripts are present in the intermandibularis
muscle in the mandibular primordia (Fig. 4H and data not
shown). In addition, Sfrp-2 transcripts are associated with a
muscle medial to the eye (Fig. 4H).
In contrast, Frzb expression is initially more widespread
and appears to mark all neural crest-derived mesenchyme.
A lateral view at stage 20 (Fig. 4E) shows widespread
expression in the facial primordia with an apparent dorso-
ventral boundary which may correspond to the neural
crest–mesoderm boundary (see review by Noden, 1988).
Analysis on tissue sections shows that there is a graded
expression with Frzb transcripts being more highly ex-
pressed in the more distal regions of the developing facial
primordia (Fig. 4E and data not shown). As the face devel-
ops, Frzb expression becomes more restricted. At stage 24,
mesenchymal expression is downregulated in the frontona-
sal mass compared to the other primordia (Fig. 4G). By stage
28, Frzb is expressed at highest levels in the mesenchyme at
the distal tips of the frontonasal mass, throughout the
lateral nasal process, and in the medial region of the
maxillary primordia (Fig. 4I). In the mandibular primordia,
Frzb is expressed in the developing Meckel’s cartilage (Fig.
4I).
Trunk
At stage 9, Sfrp-2 expression is undetectable in the
somites but by stage 12, Sfrp-2 transcripts are found
throughout the dermamyotome in the more developed
somites (Fig. 3O). By stage 20, expression in the dermamyo-
tome is restricted to the small region in the dorsal medial
lip in all somites (Figs. 5A and 5C). In addition, with the
exception of the somites anterior to the forelimb, which
give rise to the tongue muscles, expression is also detect-
able in the ventral lateral lip of the dermamyotome thatFIG. 4. Expression of Sfrp-2 and Frzb during cranial
development. Whole-mount in situ hybridisation showing
expression of Sfrp-2 (A, D, F, H), Frzb (B, E, G, I), and slug
(C) in stage 13 (A, B, C), stage 20 (D, E), stage 24 (F, G), and
stage 28 (H, I) heads. (A, B, and C) Dorsal views; (D and E)
lateral views; (F–I) frontal views. Initially, Sfrp-2 is expressed
in the otic placode, whilst Frzb is expressed in the cranial
eural crest (white arrows). The epibranchial placodes in D
nd E are marked by arrowheads. f, frontonasal mass; i, region
f intermandibularis muscle; l, lateral nasal process; m, region
f eye muscle; md, mandibular primordium; mx, maxillary
rimordium; op, otic placode. In all images, anterior is upper-gives rise to the muscles of the limb and body wall (Figs. 5A
s of reproduction in any form reserved.
190 Ladher et al.FIG. 5. Expression of Sfrp-2 and Frzb in the developing trunk. (A and B) Whole-mount in situ hybridisation showing expression of Sfrp-2
in a stage 27 trunk and Frzb in a stage 23 trunk, respectively. (C and D) Vibratome sections through (A) and (B) respectively showing
expression of Sfrp-2 in the dorsal medial and ventral lateral lip of the dermamyotome, the myotome, and the migrating muscle precursors
(arrowheads), whilst Frzb is in the sympathetic ganglia and dorsal root ganglia together with the ventral roots (long arrow in D). dml, dorsal
medial lip; drg, dorsal root ganglia; my, myotome; syg, sympathetic ganglia; vll, ventral lateral lip.
b191Sfrp-2 and Frzb during Chick DevelopmentFIG. 7. Expression of Sfrp-2 and Frzb in the developing heart. Whole-mount in situ hybridisation showing expression of Sfrp-2 (A) and Frzb
(C) in a stage 24 heart. Section analysis through the ventricle shows restricted expression of Sfrp-2 to the trabeculae (arrowed) and overlying
endocardial cell layer (B), whilst a section through the outflow tract and atrioventricular cushions shows Frzb expression in the outflow and
atrioventricular cushion mesenchyme (outlined by dashes) and overlying endocardial cells but not in underlying myocardium (D). av,
atrioventricular canal; la, left atrium; oft, outflow tract; ra, right atrium; v, ventricle.
FIG. 8. Overexpression of Sfrp-2 and Frzb dorsalises the Xenopus embryo. One ventral blastomere of the four-cell staged Xenopus embryo
was injected with 1 ng of RNA. (A) Uninjected stage 36 embryo. (B) Sfrp-2-injected embryo lacking posterior structures (e.g., tail). This
embryo also has head defects, which were seen in 25% of the embryos, including poor differentiation of the eye. (C) Frzb-injected embryo
lacking posterior structures (e.g., tail). In contrast to Sfrp-2-injected embryos, these embryos did not show head defects. (D) Section of a
normal eye from an uninjected embryo. Note the three-layered structure of the retina. (E and F) Sections of abnormal eyes from Sfrp-2- (E)
and Frzb- (F) injected embryos. Note the disrupted organisation of the retina. (G–I) Sections through control (G), Sfrp-2-injected (H), and
Frzb-injected (I) embryos. The notochord is arrowed in (G–I). Note the highly enlarged notochord in the Sfrp-2-injected embryo.FIG. 6. Expression of Sfrp-2 and Frzb in the developing limb. Whole-mount in situ hybridisation showing expression of Sfrp-2 (A–D) and
Frzb (E–H) in leg buds at stage 20/21 (A, E), stage 23 (B, F), stage 27 (C, G), and stage 30 (D, H). (I–L) Radioactive in situ hybridisation to tissue
sections. (I) Transverse section through a stage 28 leg showing expression of Sfrp-2 in the mesenchyme around the muscles. (J and K)
Adjacent transverse sections through a stage 24 wing showing expression of Frzb (J) and Sox9 (K) in the central core mesenchyme of the limb
ud. (L) Longitudinal section through a stage 32 leg showing Frzb in the perichondrium and epiphyses of the differentiating digits. (I)Photographed under light field; (J–L) photographed under dark field. c, cartilage element; j, joint; m, muscle; pc, perichondrium.
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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192 Ladher et al.and 5C). Sfrp-2 transcripts are also expressed in the migrat-
ing muscle precursors (Fig. 5C).
In contrast, Frzb expression is found in the ventral
migrating neural crest in the trunk at stages 9 and 12 with
some expression also being detectable in the dorsal streams
at stage 12 (data not shown). By stage 20, Frzb is expressed
n the sympathetic ganglia and all the dorsal root ganglia,
hich are derivatives of the ventral migrating neural crest
n the trunk, and this expression continues until at least
tage 28 (Figs. 5B and 5D).
Limb Development
Sfrp-2 is expressed in the proximal mesenchyme in asso-
ciation with developing muscles in the limb bud between
stages 20 and 30 (Figs. 6A–6D and 6I). Initially, Sfrp-2
appears to be expressed in the migrating myoblasts, which
is consistent with its expression in the ventral lateral lip of
the dermamyotome (Figs. 5A and 5C). However, between
stages 27 and 30, Sfrp-2 is expressed in the mesenchyme,
which contains undifferentiated myogenic cells, and
around the developing muscles but not in the differentiated
muscles themselves (Fig. 6I). It is difficult to distinguish
myogenic precursors from the surrounding mesenchyme.
However, the proximal expression of Sfrp-2 correlates with
the known location of myogenic precursors, suggesting that
the Sfrp-2 expression in the limb probably continues to be
restricted to undifferentiated myoblasts (Williams and Or-
dahl, 1994).
In contrast, Frzb expression is associated with chondro-
genesis. Initially, at stage 12, Frzb is expressed weakly in
the lateral plate mesoderm and by stage 18, low levels of
Frzb are detectable in the developing limb bud (Figs. 3Q and
3S and data not shown). By stage 20, Frzb is highly ex-
pressed in the ventral mesenchyme of both fore- and hind-
limb buds but by stage 24, expression is localised to the
central core of the developing limb bud, which contains the
chondrogenic precursors as determined by comparison with
Sox9 expression on adjacent sections (Figs. 6E, 6F, 6J, and
6K and data not shown). Similarly at stages 27 and 30, Frzb
expression encompasses both prechondrogenic and the sur-
rounding nonchondrogenic mesenchyme (Figs. 6G and 6H).
Following differentiation of the chondrocytes into the three
chondrogenic layers, Frzb expression becomes restricted to
the perichondrium and to the epiphyses of the early devel-
oping skeletal elements (Fig. 6L).
Heart
Sfrp-2 expression is restricted to the myocardial and
endocardial cell layers of the trabeculae in the ventricular
compartment between stages 20 and 28 (Figs. 7A and 7B).
Frzb is initially expressed in the endocardial cells of the
utflow tract from stage 15 (data not shown). By stage 18,
rzb is expressed in the endocardial and mesenchymal cells
throughout the developing atrioventricular canal and the
outflow tract cushions and this expression persists until at a
Copyright © 2000 by Academic Press. All righteast stage 26 (Figs. 7C and 7D). The myocardial layers do
ot express Frzb (Fig. 7D).
Sfrp-2 and Frzb are Wnt Antagonists
Sfrp-2 contains a frizzled domain that may directly bind
and inhibit members of the Wnt gene family. Since the
phenotypes resulting from overexpression of Wnt genes in
early Xenopus embryos have been well characterised, we
have used this system to test the role of Sfrp-2 in regulating
Wnt signalling. Injection of mRNA for members of the
Wnt-1 subgroup, including Xwnt-8, dorsalises ventral me-
soderm and induces a complete secondary axis when ex-
pressed in ventral blastomeres (McMahon and Moon, 1989;
Christian et al., 1991; Smith and Harland, 1991; Sokol et
al., 1991; Chakrabarti et al., 1992). In contrast, injection of
a plasmid containing the Xwnt-8 cDNA under the control
of a cytoskeletal actin promoter, such that expression
occurs in late blastulae/early gastrulae, ventralises dorsal
mesoderm and the resulting embryos lack anterior struc-
tures (Christian and Moon, 1993). Injection of mRNA for
Frzb, or a dominant-negative Xwnt-8, inhibits the late
ventralising activity of Xwnt-8, resulting in hyperdorsalised
embryos (Hoppler et al., 1996; Leyns et al., 1997; Wang et
al., 1997).
One nanogram of Sfrp-2 or Frzb mRNA was injected into
single ventral blastomere at the four-cell stage and em-
ryos were allowed to develop until stage 36. Localised
verexpression of Sfrp-2 on the ventral side of the embryo
id not result in the formation of secondary axes, although
few secondary axes (4/30) were seen for Frzb as previously
eported (Leyns et al., 1997; Wang et al., 1997). Most
njected embryos were hyperdorsalised with a loss of ven-
roposterior structures (Figs. 8A, 8B, and 8C), although
any Sfrp-2-injected embryos (approximately 25%) also
ad head defects (Fig. 8B). Injected embryos were scored
sing the dorsoanterior index (DAI) of Kao and Elinson
1988) in which normal embryos have a DAI score of 5
hile fully dorsalised embryos have a DAI score of 10.
frp-2-injected embryos had a higher DAI score (DAI 5 6.6;
5 35) than Frzb-injected embryos (DAI 5 5.8; N 5 26),
ndicating a greater degree of dorsalisation. This was con-
rmed by sectioning injected embryos, Sfrp-2-injected em-
ryos having a greatly enlarged notochord (Fig. 8H) com-
ared to Frzb-injected embryos (Fig. 8I) and uninjected
ontrols (Fig. 8G). We also noted that the organisation of the
etina was disrupted in both Sfrp-2- and Frzb-injected em-
ryos (Figs. 8D, 8E, and 8F). These results are consistent
ith Sfrp-2 and Frzb inhibiting the ventralising activity of
wnt-8 during gastrula stages.
We next tested the ability of both Frzb and Sfrp-2 to block
he induction of Siamois by Xwnt-8. The transcription
actor Siamois has been shown to respond to Wnt signalling
n the early Xenopus embryo (Carnac et al., 1996; Brannon
t al., 1997). Animal caps from embryos previously injected
ith either 20 pg of Xwnt-8 mRNA or with 20 pg of Xwnt-8nd 2 ng of either Sfrp-2 or Frzb mRNAs were assayed for
s of reproduction in any form reserved.
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193Sfrp-2 and Frzb during Chick Developmentthe presence of siamois transcripts using RT-PCR at early
gastrula stages (stage 10.5). In control animal caps, very
little siamois is detected (Fig. 9, lane 3), while injection of
wnt-8 RNA induced the expression of siamois (Fig. 9, lane
4) as had been shown by other workers (Carnac et al., 1996).
However, coexpression of Xwnt-8 with either Sfrp-2 or Frzb
mRNA blocked this induction (Fig. 9, lanes 5 and 6,
respectively). These results indicate that both Sfrp-2 and
Frzb are able to block Xwnt-8 signalling.
To further test whether Sfrp-2 can inhibit Wnt-mediated
dorsalisation we have used a VMZ assay in which Xwnt-8
induces the formation of dorsal mesoderm, including
muscle. Both ventral blastomeres were injected at the
four-cell stage with either 20 pg of Xwnt-8 mRNA or 20 pg
f Xwnt-8 and 2 ng of either Sfrp-2 or Frzb mRNA. VMZs
were isolated from early gastrulae (stage 10.5) and allowed
to develop until sibling embryos had reached stage 30.
Muscle and blood were detected by a double whole-mount
immunostaining protocol using the 12/101 anti-muscle
monoclonal antibody together with an anti-globin poly-
clonal antibody (Fig. 10A). VMZs isolated from either
uninjected controls (Fig. 10B) or Sfrp-2- or Frzb-injected
embryos (data not shown) did not elongate during gastrula
stages and show characteristic staining for globin. However,
they failed to differentiate any muscle, demonstrating that
Sfrp-2 and Frzb have no intrinsic dorsalising activity of their
own. In contrast, Xwnt-8-injected VMZs elongated substan-
tially during gastrula stages, indicative of dorsalisation, and
muscle was subsequently detected in all such explants, as
expected from the known dorsalising activity of this mole-
cule when overexpressed by mRNA injection (Fig. 10C).
Globin was never detected. Consistent with a role for Sfrp-2
and Frzb in regulating Wnt function, VMZs co-injected
with Xwnt-8 and either Sfrp-2 or Frzb mRNAs exhibited
greatly reduced elongation compared to VMZs injected
with Xwnt-8 alone (Figs. 10C, 10D, and 10E). Moreover,
most co-injected VMZs failed to differentiate any muscle
(Figs. 10D and 10E) but the ventral marker globin was
FIG. 9. Sfrp-2 and Frzb inhibit induction of Siamois by Xwnt-8.
RT-PCR analysis showing siamois and Ef-1a expression in animal
caps from embryos injected with Xwnt-8 mRNA alone or together
with Sfrp-2 or Frzb mRNAs. Lane 1 is a negative control (a PCR
sing RNA from a stage 10.5 embryo), whilst lane 2 shows the
ositive control from cDNA made from the same batch of RNA.
anes 3–8 show expression in animal caps from control (3) and
wnt-8- (4), Xwnt-8- and Sfrp-2- (5), and Xwnt-8- and Frzb- (6)
injected embryos. PCR products were analysed on an agarose gel.expressed in these explants. Our results suggest that Sfrp-2
Copyright © 2000 by Academic Press. All rightand Frzb can block the early dorsalising effects of Wnt-8
signalling.
DISCUSSION
Here we describe the cloning and expression of the chick
homologues of Sfrp-2 and Frzb. We show that Sfrp-2, as
previously reported for Frzb in Xenopus, can function as a
Wnt antagonist. The major sites of Sfrp-2 expression are in
he developing neuronal structures and regions of myogen-
sis, whilst Frzb transcripts are localised to four main
regions of the embryo—the neural plate, neural crest and
some derivatives, areas of chondrogenesis, and the heart.
The Wnt genes have a number of different roles during
development varying from controlling patterning to prolif-
eration, cell adhesion, and differentiation (reviewed by Parr
and McMahon, 1994; Wodarz and Nusse, 1998). The expres-
sion patterns of Sfrp-2 and Frzb suggest that these proteins
ay be important in modulating several of these processes.
FIG. 10. Sfrp-2 and Frzb can inhibit Xwnt-8-mediated dorsalisa-
tion. Ventral marginal zone explants were taken from embryos that
were injected with the indicated mRNAs, and muscle was detected
by whole-mount immunolocalisation using the muscle-specific
12/101 antibody and is stained blue, whilst globin, a ventral
marker, is shown by red staining. (A) Control whole embryo
showing normal 12/101 localisation in the somites and globin
ventrally. (B) Uninjected ventral marginal zone explants do not
contain any muscle. (C) Xwnt-8-injected (20 pg) ventral marginal
zones differentiate muscle. (D and E) Co-injection of either Sfrp-2 (2
g) (D) or Frzb (2 ng) (E) blocks most muscle differentiation in
Xwnt-8-injected (20 pg) ventral marginal zones.
s of reproduction in any form reserved.
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194 Ladher et al.Sfrp-2 Is a Wnt Antagonist
Previous studies have shown that Frzb antagonises Wnt
signalling and that this is achieved by direct binding be-
tween its CRD and Wnts (Bhanot et al., 1996; Lin et al.,
997; Wang et al., 1997; Lescher et al., 1998; Bafico et al.,
999). In this study, functional analysis in Xenopus showed
hat Sfrp-2, like Frzb, antagonises signalling by Wnt-8. First,
njection of mRNA for either Sfrp-2 or Frzb hyperdorsalises
enopus embryos, but does not dorsalise ventral marginal
ones isolated from early gastrulae or induce secondary
orsal axes when injected ventrally. These results are
imilar to those previously obtained with RNA transcripts
ncoding Xenopus Frzb and a dominant-negative mutation
f Wnt-8 (Hoppler et al., 1996; Leyns et al., 1997; Wang et
l., 1997), both of which inhibit the ventralising activity of
nt-8 during gastrulation. Second, injection of mRNA for
ither Sfrp-2 or Frzb can block the dorsalising activity of
o-injected Wnt-8 mRNA in a ventral marginal zone assay.
hus, the majority of VMZ explants do not express muscle
arkers. Although we have not directly shown this, our
esults are consistent with inhibition being mediated by
inding of Wnt-8 by Sfrp-2, probably through the CRD.
Overexpression of Frzb and Sfrp-2 disrupted the retina
uch that it was involuted and disorganised. In the mouse,
t least two Wnt molecules, Wnt-7b and Wnt-13, and at
east three Wnt antagonists, Sfrp-1, -2, and -4, are expressed
in the presumptive retina (Parr et al., 1993; Leimeister et
al., 1998; Jasoni et al., 1999). Wnt-13 has been proposed to
control/initiate differentiation, whilst Sfrp-2, which is ex-
pressed in the proliferating neural cells, has been proposed
to control proliferation (Leimeister et al., 1998; Jasoni et al.,
1999). This suggests that an interplay of Wnt/Wnt antago-
nist expression may control proliferation versus differentia-
tion in the developing retina and may be consistent with
the eye phenotype that resulted from overexpression of
Sfrp-2 or Frzb in Xenopus.
Expression of Sfrp-2 and Frzb
Neuronal development. In a number of regions, Sfrp-2
and Frzb are expressed in developing neuronal structures
and differentiated neurones. For example, both are ex-
pressed in the early neural plate and developing CNS. In
addition Sfrp-2 is found in the otic, epibranchial, and
lfactory placodes, which give rise to neurones, whilst in
he trunk, Frzb transcripts are found in the dorsal root and
sympathetic ganglia derived from neural crest. The expres-
sion of Sfrp-2 is similar to that reported in the developing
mouse (Leimeister et al., 1998; Lescher et al., 1998).
The Wnts are known to play essential roles during CNS
evelopment, controlling both patterning and development
f the neuronal structures at a cellular level. Knockout of
nt-1 function in mice results in the loss of the midbrain
nd rostral hindbrain (McMahon and Bradley, 1990) with
ncreased apoptosis contributing to some of this loss (Ser-
edzija et al., 1996), showing that at least one of the Wnts
Copyright © 2000 by Academic Press. All rightontrols the development of specific regions of the CNS.
xpression of Sfrp-2 and Frzb overlaps with that of Wnt-1,
uggesting that Frzb and Sfrp-2 may modulate Wnt-1 func-
ion in specific regions. In addition, these antagonists
verlap with Wnt-8c in the most recently formed neural
late/tube, possibly suggesting that downregulation of
nt-8c function is essential for the progression of neuro-
enesis. Although to date Wnts have not been shown to
ave a role in dorsoventral patterning of the neural tube
Ikeya et al., 1997), the differential expression of Wnts
cross the dorsoventral axis suggests that Wnts may be
nvolved in patterning along this axis. For example, the
xpression of Wnt-1, Wnt-3, Wnt-3a, and Wnt-4 is restricted
orsally (Roelink and Nusse, 1991; Parr et al., 1993; Holly-
ay et al., 1995; Ikeya et al., 1997). Sfrp-2 and Frzb expres-
ion is regionalised along the anteroposterior and dorsoven-
ral axes of the neural tube, suggesting that they may
odify Wnt signalling and hence patterning along these
xes. In addition, they may modulate cell proliferation.
nockout of both Wnt-1 and Wnt-3a function in mice
esults in a decrease in neural crest derivatives and it is
ossible that Sfrp-2 and Frzb expression modulates levels of
nt signalling, controlling proliferation of the dorsal neural
ube and hence development of the neural crest precursors
Ikeya et al., 1997). Finally, as Wnt signalling from the
dorsal neural tube is needed for myogenesis in the adjacent
somite, the coexpression of Wnts together with their puta-
tive antagonists may block autocrine signalling in the
neural tube but allow paracrine signalling to the somites.
In addition, Wnt signalling has been implicated in sen-
sory neurogenesis. At least one member of the Wnt family,
Wnt-4, is able to induce the expression of neurotrophin-3,
which is necessary for the survival of most sensory neu-
rones, in the limb bud mesenchyme (Patapoutian et al.,
1999). Sfrp-2 and neurotrophin-3 are expressed in similar
regions in the developing limb bud and Sfrp-2 has been
shown to bind Wnt-4 (Lescher et al., 1998; Patapoutian et
al., 1999). Thus, in the developing limb bud, Sfrp-2 may
modulate Wnt-4 signalling and hence neurogenesis.
Neural crest development. Frzb is expressed in the
cranial neural crest that gives rise to the skeletal structures
and some neuronal derivatives of the facial primordia and
part of the outflow tract of the heart. In the trunk, Frzb is
expressed in some neuronal derivatives of the neural crest,
i.e., the sympathetic and dorsal root ganglia. In zebrafish,
Wnt signalling has been shown to control neural crest
differentiation (Dorsky et al., 1998). Expression of Wnt-1 or
Wnt-3a promotes pigment differentiation, whereas loss of
function of Wnt signalling favours neuronal differentiation
(Dorsky et al., 1998). Thus, the expression of Frzb, which
can antagonise Wnt-1 signalling in Xenopus, in the neural
crest may be important in controlling differentiation. In
addition, Frzb activity may modulate proliferation of neural
crest/neural crest precursors as discussed earlier.
Sites of epithelial–mesenchymal interactions. In at
least two regions of the embryo, the face and limb, Sfrp-2
and Frzb may be involved in epithelial–mesenchymal inter-
s of reproduction in any form reserved.
195Sfrp-2 and Frzb during Chick Developmentactions. Frzb is initially expressed in the ventral mesen-
chyme of the limb buds and throughout most of the facial
mesenchyme. The expression pattern in the early develop-
ing limb suggests that Frzb may be involved in dorsoventral
patterning, possibly by antagonising the Wnt-7a signal from
the dorsal epithelium. However, as Wnt-7a signalling is
likely to be restricted to a few cell layers, the significance of
the complementary expression patterns of these genes is
unclear. It is more probable that Frzb modulates signalling
from other Wnts such as Wnt-4 and Wnt-7b, which are
expressed in the overlying ventral epithelium (Parr et al.,
1993; Patapoutian et al., 1999). The expression of Wnts in
the face has not been fully evaluated (reviewed by Francis-
West et al., 1998). However, in the mouse, Wnt-3 and
Wnt-3a are expressed in the mandibular epithelium overly-
ing Frzb expression (Roelink and Nusse, 1991), whilst
Wnt-5a, which is essential for facial outgrowth, is coex-
pressed in the migrating cranial neural crest and facial
mesenchyme (Gavin et al., 1990; Yamaguchi et al., 1999).
Frzb cannot antagonise Wnt-3a and Wnt-5a signalling in
Xenopus so it is unclear how, and if, these proteins would
interact. However, there is some evidence that Frzb can
enhance the effects of Wnt-5a at least in Xenopus (Lin et al.,
1997). Sfrp-2 may also modulate epithelial–mesenchymal
interactions. In particular, Sfrp-2 in the limb bud may
modulate Wnt induction of sensory neurogenesis as dis-
cussed above and possibly myogenesis as discussed below.
During chondrogenesis. Frzb is expressed in precon-
densing mesenchyme in the limbs and face as previously
reported in humans and mice (Hoang et al., 1996, 1998). A
number of Wnts have been shown to block chondrogenic
differentiation in vivo and in vitro (Rudnicki and Brown,
1997; Kawakami et al., 1999). Thus, Frzb may promote
cartilage development by blocking Wnt activity. However,
to date, the complete expression of Wnts during cartilage
development has not been reported, although Wnt-11 has
been shown to be expressed in the developing perichon-
drium in humans (Lako et al., 1998). Therefore, how Wnt/
Frzb interactions control chondrogenesis has yet to be
elucidated.
During myogenesis. In several regions of the developing
embryo, the expression of Sfrp-2 appears to be associated
with myogenesis. In the somites, Sfrp-2 expression is found
in the dorsal medial and ventral lateral lips of the der-
mamyotome, whilst in the limb bud and developing face,
Sfrp-2 is expressed in the myogenic regions.
Muscle development has been most well characterised in
the somites where Wnt signalling from the dorsal ectoderm
and dorsal neural tube, together with Sonic hedgehog sig-
nalling, is essential for the development of the myotome
(Mu¨nsterberg et al., 1995; Stern et al., 1995; Fan et al., 1997;
Hirsinger et al., 1997; Marcelle et al., 1997; Capdevila et al.,
1998; Ikeya and Takada, 1998). To date, Wnt-1, Wnt-3,
Wnt-4, Wnt-5a, Wnt-6, and Wnt-7a have all been shown to
be able to induce myogenesis, to varying degrees, in ex-
planted somites, consistent with the expression of Wnts in
the dorsal ectoderm and the dorsal neural tube (Mu¨nster-
Copyright © 2000 by Academic Press. All rightberg et al., 1995; Stern et al., 1995; Tajbakhsh et al., 1998).
Furthermore, it has been proposed that different Wnts may
activate distinct myogenic pathways (Tajbakhsh et al.,
1998). The expression of a putative antagonist, Sfrp-2, in the
developing myotome, in association with Wnt-6 and
Wnt-11 in the medial lip, would appear to be contradictory
to the muscle-inducing ability of Wnts (Parr et al., 1993;
Christiansen et al., 1995; Tanda et al., 1995; Marcelle et al.,
1997). However, Sfrp-2 may prevent precocious differentia-
tion of the developing myoblasts until they have reached
their destination or may selectively antagonise one group of
Wnts promoting one myogenic pathway. Support for the
former idea has recently been obtained for Frzb, which is
expressed in the myotome in mice. Overexpression of Frzb
in developing somites blocks expression of Myf-5 and
MyoD, determinants of myogenic differentiation (Borello et
al., 1999). Later in development, in the face and limb, Sfrp-2
is expressed in regions of myogenesis in association with
Wnt-11 expression, where again, Sfrp-2 may modulate
muscle differentiation (Christiansen et al., 1995; Tanda et
al., 1995; Kawakami et al., 1999).
Wnts control development by a variety of mechanisms
such as by modulating cell adhesion, proliferation, cell
transformation, and differentiation. The Wnt antagonists
are expressed in a number of regions where they may act to
modulate these processes. For example, the expression of
Frzb in the cardiac cushions suggests that Wnt signalling
may be involved in epithelial–mesenchymal transforma-
tion, whilst its expression in condensing mesenchyme may
increase cell adhesion essential for the initial steps of
chondrogenesis. The most striking expression pattern of
Sfrp-2 is in the neuronal structures, such as the neural plate
and some of the placodes, and in regions of muscle devel-
opment in the somites and limb. In these regions Sfrp-2
expression may control proliferation and/or differentiation.
Further investigations will fully elucidate the role of Sfrp-2
and Frzb in these processes. The role of the Sfrps may not be
just the direct antagonism of Wnt proteins. Recent work
has suggested that these Wnt antagonists may also act as
agonists (Lin et al., 1997), increasing the complexity of
these signalling interactions.
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